Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017-2021.
Antibiotic resistance
Antimicrobial
Bacteriology
Epidemiology
Pacific islands
Public health surveillance
Journal
The Lancet regional health. Western Pacific
ISSN: 2666-6065
Titre abrégé: Lancet Reg Health West Pac
Pays: England
ID NLM: 101774968
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
01
11
2022
revised:
15
12
2022
accepted:
19
12
2022
entrez:
17
2
2023
pubmed:
18
2
2023
medline:
18
2
2023
Statut:
epublish
Résumé
There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control. We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries - the Cook Islands, Kiribati, Samoa and Tonga - between 2017 and 2021. We focused on four bacteria that have been identified as 'Priority Pathogens' by the World Health Organization: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy. Supported by the National Health and Medical Research Council.
Sections du résumé
Background
UNASSIGNED
There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control.
Methods
UNASSIGNED
We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries - the Cook Islands, Kiribati, Samoa and Tonga - between 2017 and 2021. We focused on four bacteria that have been identified as 'Priority Pathogens' by the World Health Organization:
Findings
UNASSIGNED
Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was
Interpretation
UNASSIGNED
Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy.
Funding
UNASSIGNED
Supported by the National Health and Medical Research Council.
Identifiants
pubmed: 36798514
doi: 10.1016/j.lanwpc.2022.100677
pii: S2666-6065(22)00292-9
pmc: PMC9926303
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100677Informations de copyright
© 2022 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors have no relevant conflicts of interest to declare.
Références
Int J Infect Dis. 2019 Aug;85:203-211
pubmed: 31229615
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:90-103
pubmed: 18154532
Antimicrob Resist Infect Control. 2021 Mar 31;10(1):63
pubmed: 33789754
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Antibiotics (Basel). 2020 Mar 31;9(4):
pubmed: 32244420
Med J Aust. 2017 Nov 6;207(9):388-393
pubmed: 29092696
Emerg Infect Dis. 2011 Jun;17(6):1023-9
pubmed: 21749763
Lancet Reg Health West Pac. 2022 Mar 28;22:100438
pubmed: 35373162
Pharm Pract (Granada). 2007 Jan;5(1):36-41
pubmed: 25214916
Expert Rev Anti Infect Ther. 2017 Jul;15(7):663-676
pubmed: 28580804
Antibiotics (Basel). 2019 Mar 19;8(1):
pubmed: 30893880
Dermatol Clin. 2011 Jan;29(1):21-32
pubmed: 21095524
BMC Med. 2019 Mar 29;17(1):70
pubmed: 30922309
Infect Dis Clin North Am. 2019 Mar;33(1):231-245
pubmed: 30712764
J Glob Antimicrob Resist. 2022 Sep;30:286-293
pubmed: 35738385
BMC Infect Dis. 2014 Mar 24;14:160
pubmed: 24655406
J Antimicrob Chemother. 2005 Apr;55(4):506-10
pubmed: 15743899